May 13, 2013
Masayo Tada, President, DSP Dainippon Sumitomo Pharma (DSP) President Masayo Tada said at an earnings conference on May 9 that the company will increase the number of its sales force for the atypical antipsychotic Latuda (lurasidone) in North America to...read more